ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - mupirocin 2 g / 100 g - ointment - mupirocin - acute primary bacterial skin infections susceptible to the drug e.g. impetigo and folliculitis.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate 125 mg / 5 ml; clavulanic acid as potassium 31.25 mg / 5 ml - suspension - ampicillin and enzyme inhibitor - fot the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused also by beta-lactamase producing organisms which are susceptible to augmentin and are resistant to other beta-lactam antibiotics.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - טבליות מצופות פילם - amoxicillin as trihydrate 875 mg; clavulanic acid as potassium salt 125 mg - ampicillin and enzyme inhibitor - ampicillin and enzyme inhibitor - short-term treatment of bacterial infections at the following sites: upper/lower respiratory tract infections, genito-urinary tract infections, skin and soft tissue infections, bone and joint infections, dental infections and other infections.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 500 mg; clavulanic acid as potassium clavulanate 100 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactam antibiotics.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 1000 mg; clavulanic acid as potassium clavulanate 200 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactam antibiotics.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - clavulanic acid as potassium salt 57 mg / 5 ml; amoxicillin as trihydrate 400 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - otitis media, sinusitis, respiratory tract infections e.g. recurrent tonsilitis.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - clavulanic acid as potassium 200 mg/vial; ticarcillin disodium 3 g/vial - powder for solution for infusion - combinations of penicillins - timentin is an injectable antibiotic agent with a broad spectrum of bactericidal activity against a wide range of gram-positive and gram-negative, aerobic and anaerobic bacteria. the presence of clavulanate in the formulation extends the spectrum of activity of ticarcillin to include many beta-lactamase producing bacteria normally resistant to ticarcillin and other beta-lactam antibiotics. timentin is indicated for the treatment of infections in which susceptible organisms have been detected or are suspected. typical indications include: severe infections in hospitalised patients and proven or suspected infections in patients with impaired or suppressed host defences including: septicaemia, bacteraemia, peritonitis, intra-abdominal sepsis, post-surgical infections, bone and joint infections, skin and soft tissue infections, respiratory tract infections, serious or complicated renal infections (e.g. pyelonephritis), ear, nose and throat infections.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 2 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 8 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 4 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.